FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894587712> ?p ?o ?g. }

• W2894587712 endingPage "e0204352" @default.
• W2894587712 startingPage "e0204352" @default.
• W2894587712 abstract "We previously reported association of SCARB1 SNP rs10846744 with common carotid IMT (cIMT) and cardiovascular disease (CVD) events. Since rs10846744 has been reported in association with Lp-PLA2 mass and activity, we hypothesized that inflammatory pathways might mediate the association of rs10846744 with atherosclerosis.We first examined association of rs10846744 in CVD in multiple large-scale consortium-based genome-wide association studies. We further examined 27 parameters of interest, including Lp-PLA2 mass and activity, inflammatory markers, and plasma phospholipid fatty acids, and fatty acid ratios in participants from the Multi-Ethnic Study of Atherosclerosis (MESA), as potential mediators in the pathway linking rs10846744 with cIMT and incident CVD. Finally, we examined the association of rs10846744 with Lp-PLA2 activity, cardiovascular outcomes, and interaction with the Lp-PLA2 inhibitor, darapladib, in the Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy (STABILITY) and Stabilization of Plaque using Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) studies.SCARB1 rs10846744 was associated with coronary artery disease events in CARDIoGRAMplusC4D (odds ratio 1.05; 95% CI [1.02, 1.07]; P = 1.4x10-4). In combined analysis across race/ethnic groups in MESA, rs10846744 was associated with Lp-PLA2 mass (P = 0.04) and activity (P = 0.001), homocysteine (P = 0.03), LDL particle number (P = 0.01), docosahexaenoic acid [DHA] (P = 0.01), docosapentaenoic acid [DPA] (P = 0.04), DPA/ eicosapentaenoic acid [EPA] ratio (P = 0.002), and DHA/EPA ratio (P = 0.008). Lp-PLA2 activity was identified as a mediator of rs10846744 with cIMT in a basic model (P = 8x10-5), but not after adjustment for CVD risk factors. There was no interaction or modifier effect of the Lp-PLA2 inhibitor darapladib assignment on the relationship between rs10846744 and major CVD events in either STABILITY or SOLID-TIMI 52.SCARB1 rs10846744 is significantly associated with Lp-PLA2 activity, atherosclerosis, and CVD events, but Lp-PLA2 activity is not a mediator in the association of rs10846744 with cIMT in MESA." @default.
• W2894587712 created "2018-10-12" @default.
• W2894587712 creator A5005555807 @default.
• W2894587712 creator A5006952690 @default.
• W2894587712 creator A5013693923 @default.
• W2894587712 creator A5017302499 @default.
• W2894587712 creator A5020587580 @default.
• W2894587712 creator A5023858070 @default.
• W2894587712 creator A5027475930 @default.
• W2894587712 creator A5029044079 @default.
• W2894587712 creator A5047340885 @default.
• W2894587712 creator A5062843291 @default.
• W2894587712 creator A5062883630 @default.
• W2894587712 creator A5063591215 @default.
• W2894587712 creator A5070735232 @default.
• W2894587712 creator A5071844909 @default.
• W2894587712 creator A5073734270 @default.
• W2894587712 creator A5078751001 @default.
• W2894587712 creator A5080225460 @default.
• W2894587712 creator A5081943616 @default.
• W2894587712 creator A5084614356 @default.
• W2894587712 creator A5086547395 @default.
• W2894587712 date "2018-10-05" @default.
• W2894587712 modified "2023-10-15" @default.
• W2894587712 title "Lp-PLA2, scavenger receptor class B type I gene (SCARB1) rs10846744 variant, and cardiovascular disease" @default.
• W2894587712 cites W122318104 @default.
• W2894587712 cites W1572528121 @default.
• W2894587712 cites W1583413364 @default.
• W2894587712 cites W1963968515 @default.
• W2894587712 cites W1978145421 @default.
• W2894587712 cites W1990736759 @default.
• W2894587712 cites W2025219849 @default.
• W2894587712 cites W2029869170 @default.
• W2894587712 cites W2045037837 @default.
• W2894587712 cites W2049098647 @default.
• W2894587712 cites W2079121732 @default.
• W2894587712 cites W2102599455 @default.
• W2894587712 cites W2109499984 @default.
• W2894587712 cites W2110170395 @default.
• W2894587712 cites W2113187337 @default.
• W2894587712 cites W2114408062 @default.
• W2894587712 cites W2116831158 @default.
• W2894587712 cites W2117518356 @default.
• W2894587712 cites W2117913791 @default.
• W2894587712 cites W2122880159 @default.
• W2894587712 cites W2133520037 @default.
• W2894587712 cites W2137440752 @default.
• W2894587712 cites W2140479040 @default.
• W2894587712 cites W2141885792 @default.
• W2894587712 cites W2145639007 @default.
• W2894587712 cites W2156097706 @default.
• W2894587712 cites W2169832447 @default.
• W2894587712 cites W2238851414 @default.
• W2894587712 cites W2314452539 @default.
• W2894587712 doi "https://doi.org/10.1371/journal.pone.0204352" @default.
• W2894587712 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6173398" @default.
• W2894587712 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30289950" @default.
• W2894587712 hasPublicationYear "2018" @default.
• W2894587712 type Work @default.
• W2894587712 sameAs 2894587712 @default.
• W2894587712 citedByCount "2" @default.
• W2894587712 countsByYear W28945877122021 @default.
• W2894587712 countsByYear W28945877122022 @default.
• W2894587712 crossrefType "journal-article" @default.
• W2894587712 hasAuthorship W2894587712A5005555807 @default.
• W2894587712 hasAuthorship W2894587712A5006952690 @default.
• W2894587712 hasAuthorship W2894587712A5013693923 @default.
• W2894587712 hasAuthorship W2894587712A5017302499 @default.
• W2894587712 hasAuthorship W2894587712A5020587580 @default.
• W2894587712 hasAuthorship W2894587712A5023858070 @default.
• W2894587712 hasAuthorship W2894587712A5027475930 @default.
• W2894587712 hasAuthorship W2894587712A5029044079 @default.
• W2894587712 hasAuthorship W2894587712A5047340885 @default.
• W2894587712 hasAuthorship W2894587712A5062843291 @default.
• W2894587712 hasAuthorship W2894587712A5062883630 @default.
• W2894587712 hasAuthorship W2894587712A5063591215 @default.
• W2894587712 hasAuthorship W2894587712A5070735232 @default.
• W2894587712 hasAuthorship W2894587712A5071844909 @default.
• W2894587712 hasAuthorship W2894587712A5073734270 @default.
• W2894587712 hasAuthorship W2894587712A5078751001 @default.
• W2894587712 hasAuthorship W2894587712A5080225460 @default.
• W2894587712 hasAuthorship W2894587712A5081943616 @default.
• W2894587712 hasAuthorship W2894587712A5084614356 @default.
• W2894587712 hasAuthorship W2894587712A5086547395 @default.
• W2894587712 hasBestOaLocation W28945877121 @default.
• W2894587712 hasConcept C126322002 @default.
• W2894587712 hasConcept C134018914 @default.
• W2894587712 hasConcept C156957248 @default.
• W2894587712 hasConcept C164705383 @default.
• W2894587712 hasConcept C185592680 @default.
• W2894587712 hasConcept C19038510 @default.
• W2894587712 hasConcept C2776091944 @default.
• W2894587712 hasConcept C2777171753 @default.
• W2894587712 hasConcept C2778163477 @default.
• W2894587712 hasConcept C2778213512 @default.
• W2894587712 hasConcept C2780072125 @default.
• W2894587712 hasConcept C2781349093 @default.
• W2894587712 hasConcept C41443022 @default.

• next